Yahoo Web Search

Search results

1. • 

     Revolutionary Weight Loss: Largest Ever Obesity Study Showcases Semaglutide’s Promise

     SciTechDaily· 4 days ago

     Two important studies stemming from the largest and most prolonged clinical trial of semaglutide’s...

2. • 

     FDA Panel Rejects MDMA Therapy For PTSD, Citing Concerns Over Research Data In Setback For Advocates

     Benzinga· 9 hours ago

     A committee of advisors to the U.S. Food and Drug Administration (FDA) dealt a blow to the...

3. • Novartis leukemia drug more effective than older treatments in trial

     AOL· 5 days ago

     More detailed data unveiled at the American Society of Clinical Oncology meeting in Chicago showed that Scemblix helped 67.7% of patients achieve a major molecular response ...

4. • Axios Vitals

     Axios· 2 days ago

     Why it matters: While regulators have laid out how they think clinical trials can assess hallucinogenic substances like ecstasy and magic mushrooms as behavioral health treatments ...

5. • 

     FDA advisers vote against first MDMA therapy to treat PTSD

     CNN.com· 12 hours ago

     A federal advisory committee on Tuesday voted overwhelmingly against of the use of MDMA, commonly...

6. • BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression - BrainsWay (NASDAQ:BWAY)

     Benzinga· 2 days ago

     Transcranial Magnetic Stimulation system (Deep TMS™) allowing for the treatment of patients with major depressive disorder (MDD) ages 22 to 86, changing the previous upper age limit of 68. This ...

7. • 

     Older men die by suicide at steep rates. Here's how the VA is trying to change that

     Los Angeles Times· 1 hour ago

     It was a Friday morning and George McCune had roused himself to make the 2.4-mile trip from his...

8. • Numinus Wellness Announces Voting Results From its Annual General Meeting of Shareholders

     Morningstar· 4 days ago

     VANCOUVER, BC, May 31, 2024 /PRNewswire/ - Numinus Wellness Inc. ("Numinus" or the "Company") (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing traditional and innovative behavioral ...

9. • 

     Guest column: With FDA approval of software treatment for depression, the digital medicine...

     WRAL TechWire· 5 days ago

     In a watershed moment for digital health innovation, the FDA recently granted clearance to Rejoyn, a...

10. • 

      The FDA rejected the use of MDMA to treat PTSD

      Quartz· 23 hours ago

      The committee, which is composed of independent experts, met with Lykos representatives to review and discuss results from numerous studies, including...